Project 2: Large ncRNAs and Epigenetic Regulation in Pluripotency

项目 2:大 ncRNA 和多能性表观遗传调控

基本信息

  • 批准号:
    8206143
  • 负责人:
  • 金额:
    $ 49.28万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

Recent advances in our understanding of stem cell biology offer unprecedented hope for medical advancement. For example, it is now possible to transform fibroblasts from human skin to induced pluripotent stem cells (iPSCs) by induction of four master regulatory proteins. In turn these factors regulate a complex choreography that remodels the differentiated epigenetic landscapes to the pluripotent state. This process paves the way for limitless supply of genetically tailored cell types for transplantation medicine, drug discovery and the study of human disease. Although some progress has been made in understanding the key protein coding factors needed for IPSC reprogramming much less is known about the finely tuned genetic switches that guide this process and maintain the pluripotent state. We have recently demonstrated that large intergenic non-coding RNAs (lincRNAs) may serve as such switches in maintaining key cellular states such as pluripotency. Indeed, we recently discovered a new facet of lincRNA regulation of the human iPSC reprogramming process. Specifically, we identified lincRNA-RoR (Regulator of Reprogramming) that is required for reprogramming human fibroblast to iPSCs. Further consistent with this idea are three additional findings we recently reported: (i) Over 100 lincRNAs are directly regulated by the 'core stem-cell' transcription factors (Oct4, Sox2 and Nanog); (ii) lincRNAs interact with key chromatin modifying complexes that maintain the differentiation states of cells, and many convey their specificity; cell switches, (iii) lincRNAs exhibit distinctive gene- expression profiles similar to those of the few known master pluripotency switches. Collectively, these studies demonstrate a functionally important regulatory cascade initiated by reprogramming factors, which activate lincRNAs that have the potential to interface with and modulate downstream epigenetic machinery to successfully complete the reprogramming process. Here we aim to (1) Comprehensively identify lincRNAs involved in reprogramming (2) their functional roles in reprogramming and epigenetic regulation and (3) Their biochemical mechanisms. RELEVANCE (See instructions): Induced pluripotent stem cells is a potential revolutionary tool for disease modeling, drug screening and regenerative medicine. This proposal aims to fully characterize the roles of large intergenic non-coding RNAs (lincRNAs) and their functional relevance to establishing pluripotency and epigenetic states, which is an essential step towards ensuring that their use in biomedicine is effective and safe
我们对干细胞生物学的理解的最新进展为医学提供了前所未有的希望。 进步。例如,现在可以将来自人类皮肤的成纤维细胞转化为诱导的成纤维细胞。 多能干细胞(iPSC)通过诱导四个主要的调节蛋白。反过来,这些因素调节着 复杂的舞蹈,重塑分化的表观遗传景观的多能状态。这 这一过程为无限量供应用于移植医学、药物和生物医学的基因定制细胞类型铺平了道路。 人类疾病的发现和研究。 虽然在理解IPSC所需的关键蛋白质编码因子方面取得了一些进展, 对指导这一过程的微调基因开关的了解要少得多, 保持多能状态。我们最近证明,大的基因间非编码RNA lincRNA(lincRNA)可以在维持关键细胞状态如多能性中充当这样的开关。我确 最近发现了人类iPSC重编程过程的lincRNA调控的新方面。 具体来说,我们鉴定了重编程所需的lincRNA-RoR(Regulator of Reprogramming), 人成纤维细胞转化为iPSC。与这一观点进一步一致的是我们最近的三项额外发现, 报道:(i)超过100种lincRNA直接受“核心干细胞”转录因子(Oct 4,Sox 2 和Nanog);(ii)lincRNA与维持分化的关键染色质修饰复合物相互作用 状态的细胞,许多传达其特异性;细胞开关,(iii)lincRNA表现出独特的基因- 表达谱类似于少数已知的主多能性开关。总的来说,这些 研究表明,由重编程因子启动的功能重要的调节级联反应, 激活lincRNA,其具有与下游表观遗传机制相互作用并调节下游表观遗传机制的潜力, 成功地完成了重新编程过程。在这里,我们的目标是(1)全面鉴定lincRNA 参与重编程(2)它们在重编程和表观遗传调节中的功能作用,以及(3)它们在重编程和表观遗传调节中的作用。 生化机制 相关性(参见说明): 诱导多能干细胞是疾病建模、药物筛选和治疗的潜在革命性工具。 再生医学该建议旨在充分表征大基因间非编码RNA的作用, (lincRNA)及其与建立多能性和表观遗传状态的功能相关性,这是一个新的研究领域。 确保其在生物医学中的使用是有效和安全的重要步骤

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John Louis Rinn其他文献

John Louis Rinn的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John Louis Rinn', 18)}}的其他基金

Regulatory Roles and Dynamics of Nuclear long-noncoding RNAs in Pluripotency
核长非编码RNA在多能性中的调控作用和动态
  • 批准号:
    9278867
  • 财政年份:
    2017
  • 资助金额:
    $ 49.28万
  • 项目类别:
Epigenetic Regulation by Large Non-Coding RNAs in the p53 Mediated DNA Damage Res
p53 介导的 DNA 损伤研究中大非编码 RNA 的表观遗传调控
  • 批准号:
    8335413
  • 财政年份:
    2011
  • 资助金额:
    $ 49.28万
  • 项目类别:
Epigenetic Regulation by Large Non-Coding RNAs in the p53 Mediated DNA Damage Res
p53 介导的 DNA 损伤研究中大非编码 RNA 的表观遗传调控
  • 批准号:
    8689016
  • 财政年份:
    2011
  • 资助金额:
    $ 49.28万
  • 项目类别:
Epigenetic Regulation by Large Non-Coding RNAs in the p53 Mediated DNA Damage Res
p53 介导的 DNA 损伤研究中大非编码 RNA 的表观遗传调控
  • 批准号:
    8876689
  • 财政年份:
    2011
  • 资助金额:
    $ 49.28万
  • 项目类别:
Epigenetic Regulation by Large Non-Coding RNAs in the p53 Mediated DNA Damage Res
p53 介导的 DNA 损伤研究中大非编码 RNA 的表观遗传调控
  • 批准号:
    8513990
  • 财政年份:
    2011
  • 资助金额:
    $ 49.28万
  • 项目类别:
Epigenetic Regulation by Large Non-Coding RNAs in the p53 Mediated DNA Damage Res
p53 介导的 DNA 损伤研究中大非编码 RNA 的表观遗传调控
  • 批准号:
    8153835
  • 财政年份:
    2011
  • 资助金额:
    $ 49.28万
  • 项目类别:
RNA and Chromatin Formation: From Discovery to Mechanism
RNA 和染色质形成:从发现到机制
  • 批准号:
    7852410
  • 财政年份:
    2009
  • 资助金额:
    $ 49.28万
  • 项目类别:
Project 2: Large ncRNAs and Epigenetic Regulation in Pluripotency
项目 2:大 ncRNA 和多能性表观遗传调控
  • 批准号:
    8717679
  • 财政年份:
  • 资助金额:
    $ 49.28万
  • 项目类别:
Project 2: Large ncRNAs and Epigenetic Regulation in Pluripotency
项目 2:大 ncRNA 和多能性表观遗传调控
  • 批准号:
    8917263
  • 财政年份:
  • 资助金额:
    $ 49.28万
  • 项目类别:
Project 2: Large ncRNAs and Epigenetic Regulation in Pluripotency
项目 2:大 ncRNA 和多能性表观遗传调控
  • 批准号:
    8379981
  • 财政年份:
  • 资助金额:
    $ 49.28万
  • 项目类别:

相似海外基金

CAREER: Biochemical and Structural Mechanisms Controlling tRNA-Modifying Metalloenzymes
职业:控制 tRNA 修饰金属酶的生化和结构机制
  • 批准号:
    2339759
  • 财政年份:
    2024
  • 资助金额:
    $ 49.28万
  • 项目类别:
    Continuing Grant
Leveraging releasable aryl diazonium ions to probe biochemical systems
利用可释放的芳基重氮离子探测生化系统
  • 批准号:
    2320160
  • 财政年份:
    2023
  • 资助金额:
    $ 49.28万
  • 项目类别:
    Standard Grant
Diurnal environmental adaptation via circadian transcriptional control based on a biochemical oscillator
基于生化振荡器的昼夜节律转录控制的昼夜环境适应
  • 批准号:
    23H02481
  • 财政年份:
    2023
  • 资助金额:
    $ 49.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Systematic manipulation of tau protein aggregation: bridging biochemical and pathological properties
tau 蛋白聚集的系统操作:桥接生化和病理特性
  • 批准号:
    479334
  • 财政年份:
    2023
  • 资助金额:
    $ 49.28万
  • 项目类别:
    Operating Grants
Converting cytoskeletal forces into biochemical signals
将细胞骨架力转化为生化信号
  • 批准号:
    10655891
  • 财政年份:
    2023
  • 资助金额:
    $ 49.28万
  • 项目类别:
Enhanced Biochemical Monitoring for Aortic Aneurysm Disease
加强主动脉瘤疾病的生化监测
  • 批准号:
    10716621
  • 财政年份:
    2023
  • 资助金额:
    $ 49.28万
  • 项目类别:
Biochemical Mechanisms for Sustained Humoral Immunity
持续体液免疫的生化机制
  • 批准号:
    10637251
  • 财政年份:
    2023
  • 资助金额:
    $ 49.28万
  • 项目类别:
Structural and biochemical investigations into the mechanism and evolution of soluble guanylate cyclase regulation
可溶性鸟苷酸环化酶调节机制和进化的结构和生化研究
  • 批准号:
    10604822
  • 财政年份:
    2023
  • 资助金额:
    $ 49.28万
  • 项目类别:
Chemical strategies to investigate biochemical crosstalk in human chromatin
研究人类染色质生化串扰的化学策略
  • 批准号:
    10621634
  • 财政年份:
    2023
  • 资助金额:
    $ 49.28万
  • 项目类别:
Examination of risk assessment and biochemical assessment of fracture development focusing on the body composition of patients with rheumatoid arthritis
关注类风湿性关节炎患者身体成分的骨折发生风险评估和生化评估检查
  • 批准号:
    22KJ2600
  • 财政年份:
    2023
  • 资助金额:
    $ 49.28万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了